Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation

Menopause

Volumn 18, Issue 10, 2011, Pages 1044-1051

  Thurston, Rebecca C ^a,b   El Khoudary, Samar R ^b   Sutton Tyrrell, Kim ^b   Crandall, Carolyn J ^c   Gold, Ellen ^d   Sternfeld, Barbara ^e   Selzer, Faith ^b   Matthews, Karen A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DIVISION OF RESEARCH   (United States)

Author keywords

Coagulation; Hemostasis; Hot flashes; Inflammation; Menopause; Vasomotor symptoms

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7C; C REACTIVE PROTEIN; ESTRADIOL; FIBRINOGEN; GLUCOSE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); DEMOGRAPHY; DISEASE ASSOCIATION; DRUG USE; ESTRADIOL BLOOD LEVEL; ETHNICITY; FEMALE; HOT FLUSH; HUMAN; INTERVIEW; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENOPAUSE; NIGHT SWEAT; SYMPTOM; VASOMOTOR SYMPTOM;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; C-REACTIVE PROTEIN; ESTRADIOL; FACTOR VII; FEMALE; FIBRINOGEN; HEMOSTASIS; HOT FLASHES; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; MENOPAUSE; MIDDLE AGED; SWEATING; TISSUE PLASMINOGEN ACTIVATOR; VASOMOTOR SYSTEM; WOMEN'S HEALTH;

EID: 80053251216     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31821f5d39     Document Type: Article

References (38)

1. Gold E, Colvin A, Avis N, et al. Longitudinal analysis of vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women's Health Across the Nation (SWAN). Am J Public Health 2006; 96:1226-1235. (Pubitemid 43967848)
2. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003;10:19-28. (Pubitemid 36706318)
3. Bromberger JT, Matthews KA, Schott LL, et al. Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). J Affect Disord 2007;103:267-272. (Pubitemid 47445776)
4. Avis NE, Colvin A, Bromberger JT, et al. Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women's Health Across the Nation. Menopause 2009;16:860-869.
5. Williams RE, Kalilani L, DiBenedetti DB, Zhou X, Fehnel SE, Clark RV. Healthcare seeking and treatment for menopausal symptoms in the United States. Maturitas 2007;58:348-358. (Pubitemid 350167510)
6. Freedman RR. Physiology of hot flashes. Am J Human Biol 2001;13: 453-464. (Pubitemid 32590928)
7. Sherman S, Miller H, Nerurkar L, Schiff I. Research opportunities for reducing the burden of menopause-related symptoms. Am J Med 2005;118: 166-171.
8. Tuomikoski P, Ebert P, Groop PH, et al. Evidence for a role of hot flushes in vascular function in recently postmenopausal women. Obstet Gynecol 2009;113:902-908.
9. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-1477. (Pubitemid 46556472)
10. Huang AJ, Sawaya GF, Vittinghoff E, Lin F, Grady D. Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause 2009;16:639-643.
11. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation 2008;118:1234-1240.
12. Thurston RC, Sutton-Tyrrell K, Everson-Rose S, Hess R, Powell L, Matthews K. Hot flashes and carotid intima media thickness among midlife women. Menopause 2011;18:352-358.
13. Bechlioulis A, Kalantaridou SN, Naka KK, et al. Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. J Clin Endocrinol Metab 2010;95:1199-1206.
14. Yasui T, Uemura H, Tomita J, et al. Association of interleukin-8 with hot flashes in premenopausal, perimenopausal, and postmenopausal women and bilateral oophorectomized women. J Clin Endocrinol Metab 2006;91: 4805-4808. (Pubitemid 44917311)
15. Levi M, van der Poll T, Buller HR. Bidirectional relation between inflammation and coagulation. Circulation 2004;109:2698-2704. (Pubitemid 38737913)
16. Tracy RP. Thrombin, inflammation, and cardiovascular disease: an epidemiologic perspective. Chest 2003;124:49S-57S. (Pubitemid 37128436)
17. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003;42:1149-1160. (Pubitemid 37188333)
18. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843. (Pubitemid 30165206)
19. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279:1477-1482. (Pubitemid 28228207)
20. Folsom AR. Hemostatic risk factors for atherothrombotic disease: an epidemiologic view. Thromb Haemost 2001;86:366-373. (Pubitemid 32666188)
21. Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S, Ferdousi T. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause 2005;12:258-266. (Pubitemid 40664208)
22. Randolph JF Jr, Sowers M, Bondarenko I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 2005;90: 6106-6112. (Pubitemid 41606532)
23. Cushman M. Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulation. Am J Cardiol 2002;90:7F-10F. (Pubitemid 34775145)
24. Sowers M, Crawford S, Sternfeld B, et al. SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition. In: Lobo RA, Kelsey J, Marcus R, Lobo AR, eds. Menopause: Biology and Pathology. New York: Academic Press, 2000:175-188.
25. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511. (Pubitemid 36158056)
26. England BG, Parsons GH, Possley RM, McConnell DS, Midgley AR. Ultrasensitive semiautomated chemiluminescent immunoassay for estradiol. Clin Chem 2002;48:1584-1586. (Pubitemid 34925797)
27. Ferris B. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978;118:1-120.
28. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
29. Ainsworth BE, Sternfeld B, Richardson MT, Jackson K. Evaluation of the Kaiser Physical Activity Survey in women. Med Sci Sports Exerc 2000;32:1327-1338. (Pubitemid 30482665)
30. Singer J, Willett J. Applied Longitudinal Analysis: Modeling Change and Event Occurrence. New York: Oxford University, 2003.
31. Thurston R, Christie I, Matthews K. Hot flashes and cardiac vagal control: a link to cardiovascular risk? Menopause 2010;17:456-461.
32. van Westerloo DJ, Giebelen IA, Meijers JC, et al. Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats. J Thromb Haemost 2006;4:1997-2002. (Pubitemid 44226780)
33. Saigo M, Hsue PY, Waters DD. Role of thrombotic and fibrinolytic factors in acute coronary syndromes. Prog Cardiovasc Dis 2004;46: 524-538. (Pubitemid 38781093)
34. Pradhan AD, LaCroix AZ, Langer RD, et al. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women. Circulation 2004;110:292-300. (Pubitemid 38955498)
35. Sowers MR, Matthews KA, Jannausch M, et al. Hemostatic factors and estrogen during the menopausal transition. J Clin Endocrinol Metab 2005;90:5942-5948. (Pubitemid 41606509)
36. Gast GC, Pop VJ, Samsioe GN, et al. Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease. Menopause 2011;18:146-151.
37. Thurston RC, Sowers MR, Sutton-Tyrrell K, et al. Abdominal adiposity and hot flashes among midlife women. Menopause 2008;15:429-434. (Pubitemid 351656746)
38. Thurston RC, Blumenthal JA, Babyak MA, Sherwood A. The association between hot flashes, sleep complaints, and psychological functioning among healthy menopausal women. Int J Behav Med 2006;13:163-172. (Pubitemid 43962735)